NO20014085L - Blandinger og fremgangsmåter for forbedring av integritet av kompromitterte kroppspassasjer og hulrom - Google Patents

Blandinger og fremgangsmåter for forbedring av integritet av kompromitterte kroppspassasjer og hulrom

Info

Publication number
NO20014085L
NO20014085L NO20014085A NO20014085A NO20014085L NO 20014085 L NO20014085 L NO 20014085L NO 20014085 A NO20014085 A NO 20014085A NO 20014085 A NO20014085 A NO 20014085A NO 20014085 L NO20014085 L NO 20014085L
Authority
NO
Norway
Prior art keywords
methods
cavities
mixtures
body passages
integrity
Prior art date
Application number
NO20014085A
Other languages
English (en)
Norwegian (no)
Other versions
NO20014085D0 (no
Inventor
Pierre E Signore
Lindsay S Machan
Original Assignee
Angiotech Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angiotech Pharm Inc filed Critical Angiotech Pharm Inc
Publication of NO20014085D0 publication Critical patent/NO20014085D0/no
Publication of NO20014085L publication Critical patent/NO20014085L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0076—Sprayable compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Treatment Of Sludge (AREA)
  • Soil Conditioners And Soil-Stabilizing Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Resins (AREA)
  • Saccharide Compounds (AREA)
  • Lubricants (AREA)
NO20014085A 1999-02-23 2001-08-22 Blandinger og fremgangsmåter for forbedring av integritet av kompromitterte kroppspassasjer og hulrom NO20014085L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12142499P 1999-02-23 1999-02-23
PCT/CA2000/000175 WO2000050016A2 (fr) 1999-02-23 2000-02-23 Compositions et methodes pour l'amelioration de l'integrite de cavites et de passages corporels affaiblis

Publications (2)

Publication Number Publication Date
NO20014085D0 NO20014085D0 (no) 2001-08-22
NO20014085L true NO20014085L (no) 2001-10-22

Family

ID=22396646

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014085A NO20014085L (no) 1999-02-23 2001-08-22 Blandinger og fremgangsmåter for forbedring av integritet av kompromitterte kroppspassasjer og hulrom

Country Status (16)

Country Link
US (3) US20020022055A1 (fr)
EP (1) EP1162956B8 (fr)
JP (1) JP2002537324A (fr)
KR (1) KR20010112285A (fr)
CN (1) CN1344156A (fr)
AT (1) ATE297198T1 (fr)
AU (1) AU768527B2 (fr)
CA (1) CA2369739C (fr)
DE (1) DE60020681T9 (fr)
DK (1) DK1162956T3 (fr)
ES (1) ES2243232T3 (fr)
IL (2) IL145069A0 (fr)
NO (1) NO20014085L (fr)
NZ (1) NZ513895A (fr)
PT (1) PT1162956E (fr)
WO (1) WO2000050016A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569129B1 (en) * 2000-09-13 2003-05-27 Mayo Foundation For Medical Education And Research Biological revascularization
EP1322234A2 (fr) * 2000-09-25 2003-07-02 Cohesion Technologies, Inc. Stents et obturateurs anastomotiques resorbables et leur utilisation chez des patients
JP2002154963A (ja) * 2000-11-14 2002-05-28 Yakult Honsha Co Ltd 徐放性抗腫瘍剤
RU2308954C2 (ru) * 2002-05-09 2007-10-27 Медиджинез Фармацевтическая композиция для лечения ран, содержащая плазму или сыворотку крови
JP2006515186A (ja) * 2002-09-26 2006-05-25 アンジオテック インターナショナル アクツィエン ゲゼルシャフト 血管周囲ラップ
CN1732022A (zh) * 2002-12-30 2006-02-08 血管技术国际股份公司 含有丝的支架移植物
WO2005046746A2 (fr) 2003-11-10 2005-05-26 Angiotech International Ag Implants medicaux et agents inducteurs de fibrose
WO2005112569A2 (fr) * 2004-05-13 2005-12-01 Medtronic Vascular, Inc. Procedes de melange et de distribution d'un agent therapeutique dans l'adventice d'un vaisseau
WO2006033641A1 (fr) * 2004-12-22 2006-03-30 Merlin Md Pte Ltd Dispositif medical
AU2005331924A1 (en) * 2005-05-12 2006-11-23 Angiotech International Ag Compositions and methods for treating diverticular disease
US7323184B2 (en) * 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
UY30883A1 (es) 2007-01-31 2008-05-31 Alcon Res Tapones punctales y metodos de liberacion de agentes terapeuticos
GB201505527D0 (en) 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
EP3492091B1 (fr) * 2016-07-29 2021-07-14 Tohoku University "muse"-zellen als prophylaktisches oder therapeutisches mittel für aneurysma
US11045589B2 (en) 2017-09-22 2021-06-29 Becton, Dickinson And Company 4% trisodium citrate solution for use as a catheter lock solution
CA3078555A1 (fr) 2017-10-06 2019-04-11 Foundry Therapeutics, Inc. Depots implantabes pour la liberation controlee d'agents therapeutiques
CN111655303A (zh) * 2018-01-08 2020-09-11 铸造疗法股份有限公司 经由治疗剂的控制递送用于治疗腔内癌症的装置、系统和方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797485A (en) * 1971-03-26 1974-03-19 Alza Corp Novel drug delivery device for administering drug into blood circulation in blood vessel
US4978668A (en) * 1986-09-02 1990-12-18 Purdue Research Foundation Treatment to reduce ischemic tissue injury
US5100668A (en) * 1988-06-14 1992-03-31 Massachusetts Institute Of Technology Controlled release systems containing heparin and growth factors
WO1991007154A1 (fr) * 1989-11-13 1991-05-30 President And Fellows Of Harvard College REGULATION EXTRALUMINALE DE LA CROISSANCE ET DE LA REPARATION DE STRUCTURES TUBULAIRES ιIN VIVO
US5527532A (en) * 1989-11-13 1996-06-18 President And Fellows Of Harvard College Extraluminal regulation of the growth and repair of tubular structures in vivo
US5173298A (en) * 1990-09-27 1992-12-22 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
US5540928A (en) * 1991-02-27 1996-07-30 President And Fellows Of Harvard College Extraluminal regulation of the growth and repair of tubular structures in vivo
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
ATE188375T1 (de) * 1992-11-17 2000-01-15 Yoshitomi Pharmaceutical Ein antipsychotikum enthaltende mikrokugel zur verzögerten freisetzung und verfahren für ihre herstellung
US5981568A (en) * 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
KR101222904B1 (ko) * 1993-07-19 2013-01-17 안지오테크 파마슈티칼즈, 인코포레이티드 항맥관형성 조성물, 당해 조성물로 피복된 스텐트 및 당해 스텐트의 제조방법
US5886026A (en) * 1993-07-19 1999-03-23 Angiotech Pharmaceuticals Inc. Anti-angiogenic compositions and methods of use
ES2255477T5 (es) * 1993-07-29 2010-04-08 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Uso de paclitaxel y sus derivados en la fabricacion de un medicamento para el tratamiento de reestenosis.
CA2180260A1 (fr) * 1993-12-29 1995-07-06 Dennis M. Brown Procedes et compositions utilises dans le traitement d'un hote affecte par une maladie a proliferation cellulaire
US5580899A (en) * 1995-01-09 1996-12-03 The Liposome Company, Inc. Hydrophobic taxane derivatives
US5612052A (en) * 1995-04-13 1997-03-18 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
HU226646B1 (en) * 1996-03-12 2009-05-28 Pg Txl Company Water soluble pharmaceutical compositions containing taxane derivatives
AU7972498A (en) * 1997-06-18 1999-01-04 Boston Scientific Corporation Polycarbonate-polyurethane dispersions for thrombo-resistant coatings
US5997895A (en) * 1997-09-16 1999-12-07 Integra Lifesciences Corporation Dural/meningeal repair product using collagen matrix
US5997875A (en) * 1998-03-27 1999-12-07 Zhou; James H. Herbal composition and treatment methods

Also Published As

Publication number Publication date
WO2000050016A3 (fr) 2001-01-18
IL145069A0 (en) 2002-06-30
EP1162956B8 (fr) 2005-08-10
ES2243232T3 (es) 2005-12-01
AU2787800A (en) 2000-09-14
KR20010112285A (ko) 2001-12-20
CN1344156A (zh) 2002-04-10
DK1162956T3 (da) 2005-10-10
PT1162956E (pt) 2005-10-31
CA2369739C (fr) 2008-12-16
AU768527B2 (en) 2003-12-18
NO20014085D0 (no) 2001-08-22
EP1162956A2 (fr) 2001-12-19
DE60020681D1 (de) 2005-07-14
ATE297198T1 (de) 2005-06-15
NZ513895A (en) 2001-09-28
DE60020681T2 (de) 2006-05-11
US20070104767A1 (en) 2007-05-10
WO2000050016A9 (fr) 2001-10-11
US20030124197A1 (en) 2003-07-03
CA2369739A1 (fr) 2000-08-31
IL145069A (en) 2007-06-03
WO2000050016A2 (fr) 2000-08-31
US20020022055A1 (en) 2002-02-21
JP2002537324A (ja) 2002-11-05
DE60020681T9 (de) 2006-08-31
EP1162956B1 (fr) 2005-06-08

Similar Documents

Publication Publication Date Title
NO20014085L (no) Blandinger og fremgangsmåter for forbedring av integritet av kompromitterte kroppspassasjer og hulrom
MXPA03010085A (es) Composiciones y su uso en la hiperplasia.
IL144294A0 (en) P53 inhibitors and therapeutic use of the same
MXPA03008623A (es) Combinacion farmaceutica para el tratamiento del cancer.
TR200201440T2 (tr) Biomedikal kullanım için radyum-223 hazırlanması
NO20044039L (no) Konjugatorer av terapeutiske eller cytotoksiske midler og biologisk aktive peptider.
CY1107054T1 (el) Ενωσεις διτοσυλικου αλατος κιναζολινης
DE60239707D1 (de) Antimikrobielle kationische peptide und diese enthaltende formulierungen
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
DK0944389T3 (da) Oprensede sammensætninger af 10-propargyl-10-deazaaminopterin og fremgangsmåder til anvendelse deraf i behandlingen af tumorer
DK1178726T3 (da) Vandig opløsning til konservering af væv og organer
DE69120287D1 (en) Aminosulfonylharnstoff-acat-inhibitoren
DE60129829D1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
IL161501A0 (en) Methods of preventing and treating flavivirus infection in animals
ATE332688T1 (de) Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung
WO2002074735A3 (fr) Derives de biurethane
WO2003053999A3 (fr) Inhibiteurs selectifs d'urokinase
WO2003059332A3 (fr) Traitement de l'uveite
NO20012777D0 (no) Anvendelse av riluzol ved behandling av akustiske traumer
SE0100374D0 (sv) Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof
EP1568363A3 (fr) Compositions et procédés pour l'amelioration de l'integrité des cavites et passages corporels affaiblis.
UA32280A (uk) Спосіб формування тонко-товстокишкового анастомозу бік у бік
UA32302A (uk) Спосіб усунення післяопераційних деформацій м'яких тканин
AU2002333843A1 (en) Substituted n-(1,4,5,6-tetrahydrocyclopentapyrazol-3-yl) derivatives and the use of the same for the treatment of cancer
UA32651C2 (uk) Спосіб напіввідкритої лапаростомії

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application